Rights and permissions
About this article
Cite this article
MDX-210 phase I results show activity, tolerability. Inpharma Wkly. 1007, 7 (1995). https://doi.org/10.2165/00128413-199510070-00016
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199510070-00016